Objective: To develop and validate a new standardized confusion assessment method (CAM) that enables nonpsychiatric clinicians to detect delirium quickly in high-risk settings.
Development of the Instrument The new method was adapted from the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) criteria (31).
First, the important clinical features of delirium were identified. Second, these features were specifically defined in the CAM questionnaire. Terminology that would be unfamiliar to nonpsychiatrists was clarified.
On the basis of a review of the literature (1-10, 13, 31-47) and the consensus of an expert panel, we identified nine clinical features of delirium that were considered to be of great diagnostic importance. The expert panel included four geriatricians, two neurologists, and two psychiatrists. The clinical features identified were acute onset and fluctuating course, inattention, disorganized thinking, altered level of consciousness, disorientation, memory impairment, perceptual disturbances, increased or decreased psychomotor activity, and disturbance of the sleep-wake cycle. All of these features are included in the DSM-III-R diagnostic criteria for delirium. We eliminated the requirement for a specific organic etiology, another DSM-III-R criterion, because it is not observable at the bedside and the required information is often not available at the time of initial diagnosis.
The resulting questionnaire (see Appendix Table 1 ) was based on specific observations relevant to each of the nine features of delirium. The questionnaire includes a quick rating system but also provides open-ended questions to allow richer clinical detail to be recorded, if desired.
Development of the Diagnostic Algorithm
On the basis of the DSM-III-R, the previous literature, and the expert panel, we developed, a priori, the following diagnostic algorithm for delirium. The diagnosis of delirium is based on four features: acute onset and fluctuating course (feature 1), inattention (feature 2), disorganized thinking (feature 3), and altered level of consciousness (feature 4). The diagnosis of delirium requires the presence of features 1 and 2 and either 3 or 4. The algorithm was designed to be simple, acceptable to nonpsychiatrists, and useful for rapid identification of delirium. The complete algorithm appears in Appendix Table 2 .
These four features are cardinal elements of DSM-III-R criteria (31) . Features 1 (acute onset and fluctuating course) and 2 (inattention) are identified as essential features of delirium in the DSM-III-R. The complementary designation of feature 3 (disorganized thinking) or 4 (altered level of consciousness) is supported by expert judgment and clinical practice. In the presence of a reduced level of consciousness, disorganized thinking often cannot be assessed.
The remaining five features were not included in the algorithm, because we anticipated that they would add nothing to the diagnostic sensitivity or specificity (on the basis of a review of the literature and our clinical experience). For example, memory impairment is sometimes absent in mild delirium, whereas it is present in other conditions, such as dementia.
Face and Content Validity
Face validity involves a qualitative appraisal of the sensibility of an index (48) . We asked the expert panel to rate the extent to which the CAM addresses overall concepts of delirium, as well as the specific features of delirium. Each panel member independently completed a detailed, standardized critique of the instrument and algorithm, which we then used to assess face and content validity.
Concurrent Validation

Procedure
Concurrent validity was determined by comparing the CAM ratings with those of a psychiatrist. Concurrent validation was replicated in two clinically distinct samples. At two sites (Yale University and the University of Chicago), each subject was evaluated independently by a geriatrician (S.K.I, or C.A.A.) and by a psychiatrist (C.V.D., A.P.S., or S.B.) within a maximum of 6 hours of each other. Only the geriatrician completed the CAM rating. The geriatrician and the psychiatrist were blinded to the results of each other's evaluation. The order in which patients were seen (whether by the geriatrician or the psychiatrist first) was varied. To minimize a learning effect, each investigator avoided correcting the subjects' responses.
The psychiatrist used standard psychiatric procedures to evaluate the patient and made final diagnoses in accordance with DSM-III-R criteria. The evaluation included a detailed patient interview (complete psychiatric interview and mental status examination), family interview, medical record review, and nurse interview (for inpatients). The final diagnoses of the psychiatrist, as confirmed by follow-up medical record review, were the reference standard against which the CAM was assessed.
In a standardized interview, the geriatrician administered the Mini-Mental State Examination (20) , checked immediate recall of a story (49) , and made a CAM rating and a rating on the Visual Analog Scale for Confusion (20) . In addition, either a family member or another observer (a nurse or physician) was interviewed briefly to assess whether an acute change in mental status had been noted. At site 2, an additional attention task, digit span forward (50, 51) , was done. The geriatrician did not use information from any source other than the standardized interviews to score the CAM.
Patient Selection
The selection criteria were designed to provide a group of patients who would adequately challenge the CAM; subjects were not intended to be a representative sample of elderly hospitalized patients. To establish sensitivity, we chose to examine patients whose delirium varied broadly in severity and presentation. Our goal was to discover false-negative results. To establish specificity, we challenged the CAM with a broad range of subjects without delirium, particularly those with alternative ailments that may lead to false-positive results (for example, dementia, depression, and other causes of altered mental status).
Before entering the study, the patient, their family (if indicated), and the attending physician gave informed consent. The Institutional Review Board at each institution approved the study protocol.
Study Sample at Site I
Potential subjects included consecutive patients who were being newly evaluated at the Geriatric Assessment Center and a random sample of patients who had been admitted to six general medical wards at Yale-New Haven Hospital from July 1988 to March 1989. The Geriatric Assessment Center is an outpatient, community referral-based center in which multidisciplinary geriatric assessments are done on 400 new patients per year. Yale-New Haven Hospital is an 800-bed urban teaching hospital with 200 general medical beds. At both sites, eligible patients were 65 years of age or older and were not receiving care from the geriatrician or the psychiatrist. At site 1, eligible patients had diagnoses of suspected delirium, dementia, depression, or "confusion." In addition, a random sample of patients who had normal mental status and no psychiatric diagnoses was selected at site 1.
Thirty-eight eligible patients were identified at site 1. Nine of these patients were excluded because of severe psychosis (3 patients), severe delusions or paranoia (2 patients), agitation (1 patient), or lack of cooperation or refusal (3 patients). Patients who were suspected of having dementia, depression, or both were included in the study to provide particular diagnostic challenge. Thirty patients were enrolled, including 11 (37%) from the clinic and 19 (63%) from the medical wards.
Study Sample at Site 2
Potential subjects included a selected sample of patients who had been admitted from April to June of 1989 to the general medical service at Bernard Mitchell Hospital, a 600-bed urban teaching hospital at the University of Chicago, with 150 general medical beds. At site 2, eligible patients exhibited abnormal thinking or behavior identified by the nursing staff. Unlike at site 1, at site 2 suspected depression and normal mental status were not inclusion criteria. Twenty-nine eligible patients were approached; 3 were excluded because of refusal (2 pa- tients) or inability to complete interviews within the specified time (1 patient). Twenty-six patients were enrolled at site 2.
Convergent Validity
We determined the agreement of the CAM ratings with the results of four other mental status indexes. The Mini-Mental State Examination assesses general cognitive functioning (for example, dementia) (20) ; story recall assesses memory (49); the Visual Analog Scale for Confusion assesses disorganization of thought (10) ; and the digit span assesses attention (50, 51) .
Interobserver Reliability
At site 1 only, interobserver reliability was determined by assessing the consistency of the independent ratings given simultaneously by different observers using the CAM. A separate group of 10 patients was randomly sampled from the same sampling frame used in the concurrent validation. Two researchers observed each patient simultaneously while one of them interviewed the patient. Each researcher independently and blindly completed the confusion assessment questionnaire on the basis of observations made during the interview. Nineteen paired assessments were completed on the 10 patients. Each pair of assessments was done on a different day. The concordance between these 19 assessments was determined. Test-retest reliability was not determined because of the fluctuating nature of delirium.
Ease of Use
Some training is required for optimal use of the CAM. As indicators of ease of use, we measured time for completion of cognitive testing and CAM ratings, subject tolerance, and the CAM's acceptability to clinicians and interviewers.
Statistical Analysis
For comparisons between the groups, the Student /-test and standard tests for proportions were used (52) . Sensitivity, specificity, positive predictive value, negative predictive value, and confidence intervals (CIs) for sensitivity and specificity were calculated using standard formulae (48, 52) . The likelihood ratio for a positive test was defined as follows: sensitivity/(lspecificity). The kappa (K) coefficient was calculated as the index of concordance exceeding chance for interobserver reliability and convergent validity (52) .
Results
Face and Content Validity
The expert panel agreed that the questionnaire had high face validity; that is, they agreed that each item assessed the feature of delirium that it was intended to assess and that the overall instrument would suitably assess patients with delirium. In addition, the diagnostic algorithm was anticipated to have high diagnostic sensitivity. However, the panel was concerned about the algorithm's diagnostic specificity in distinguishing between delirium and dementia. Table 1 shows the characteristics of the subjects in the concurrent validation (at both sites) and interobserver reliability groups. For purposes of validation, the CAM was applied in the same way to two clinically distinct study populations that differed significantly in race, number of acute medical problems, and distribution of study diagnoses.
Concurrent Validity
As shown in Tables 2 and 3 , at site 1 (total, 30 patients), all 10 patients whom the psychiatrist rated as being delirious were also positive according to the CAM were 20.0 and 9.4 for patients at sites 1 and 2, (sensitivity of 100%). The CAM ratings were negative for 19 of the 20 patients whom the psychiatrist rated as not being delirious (specificity of 95%). The likelihood ratio of 20.0 indicates that a subject with a rating of delirium according to the CAM is 20 times more likely to be truly delirious than not to be delirious. At site 2 (total, 26 patients), ratings were positive for 15 of the 16 patients whom the psychiatrist rated as being delirious (sensitivity of 94%). The CAM ratings were negative for 9 of the 10 patients whom the psychiatrist rated as not being delirious (specificity of 90%).
Individual Elements of the Algorithm
The presence or absence of each clinical feature was compared with the reference standard to determine the sensitivity, specificity, and likelihood ratio of that feature (Table 4) . Of the nine clinical features of delirium, the four features used in the diagnostic algorithm had the highest likelihood ratios. In addition, when analyzed according to the diagnostic algorithm for this study, the presence of features 1 and 2 and either 3 or 4 gave the best performance of all of the combinations that we examined. The remaining five clinical features, when added alone or in various combinations, did not increase the sensitivity, specificity, or likelihood ratio. Feature 4, an altered level of consciousness, had the highest likelihood ratio (ratio of 63) at site 2 because of its high specificity. However, the sensitivity of this feature is only 63%, and its greatest diagnostic contribution remains in the format of the CAM algorithm.
Convergent Validity
The CAM ratings were found to agree moderately or substantially (P < 
Ease of Use
The standardized interviews, including cognitive testing, administered by the geriatricians (S.K.I., C.A.A.) took a mean of 20 minutes and were well tolerated. Only three subjects were unable to complete the cognitive testing because of severe delirium. However, the investigators were able to complete CAM ratings on all subjects. The CAM instrument can be completed in less than 5 minutes and is well understood by physicians, nurses, and trained lay interviewers. By contrast, the psychiatrist's evaluation took a mean of 90 minutes, of which 30 to 45 minutes were spent on the patient interview. 
Discussion
We have developed and validated a new method that facilitates detection of delirium. The CAM, which includes a new instrument and standardized diagnostic algorithm, has been shown to have high sensitivity (94% to 100%), high specificity (90% to 95%), and high interrater reliability. With its high negative predictive accuracy (90% to 100%), the CAM may serve as a useful test for detection of delirium. It is particularly intended for use in groups of persons who are at high risk for the development of delirium (for example, hospitalized elderly medical and surgical patients). However, its usefulness will need to be confirmed in future studies of representative samples from the specific populations in which it will be used. Because its false-positive rate is as high as 10%, we recommend that in the clinical setting all patients with a diagnosis of delirium according to the CAM have further evaluation to confirm the diagnosis.
Although the CAM diagnoses usually agreed with those of the psychiatrist, discrepancies did occur. In the combined concurrent validation sample of 56 subjects, 3 were misclassified: 1 had a false-negative and 2 had false-positive results. All 3 of these subjects had severe underlying dementia, with inattention and disorganized thinking at baseline. Diagnosing delirium superimposed on dementia is a particularly complex problem. Greater specification or alternate diagnostic criteria may be required for this group. The discrepancies in diagnoses may also result from the geriatrician and the psychiatrist evaluating the patient at different times; the geriatrician and the psychiatrist using different sources of information; and the psychiatrist using a more detailed cognitive evaluation. The false-negative CAM rating most likely resulted from the geriatrician's use of a less detailed cognitive assessment. The two false-positive CAM ratings most likely resulted from temporal separation of the evaluations and the use of different sources of information on the acuity of the mental status change.
For this study, the CAM ratings were based on observations made during a brief, structured interview that included administration of the Mini-Mental State Examination. Although the CAM was designed for use in various clinical settings, such as in making observations during routine clinical care, its validity and reliability using alternative methods of assessment will need to be studied. Some training is required for optimal use of the CAM. The proficiency and thoroughness of the primary observations on which the CAM ratings are based may well influence the CAM's performance.
This study had several important limitations. First, relatively few persons were studied, and they were selected. Although the leading differential diagnoses for cognitive impairment in the elderly (for example, dementia, depression) were adequately tested, the broader spectrum of psychiatric diagnoses-such as schizophrenia, mania, anxiety disorders-were not sufficiently represented to assess the performance of the CAM in patients with these diagnoses. However, these conditions are infrequently seen on general medical and surgical services where the CAM is intended to be used. In addition, further testing of the CAM will be required in patients with multiple psychiatric diagnoses, such as combinations of dementia, depression, psychosis, and delirium. Because the CAM was specifically designed for use in the elderly, its performance in younger subjects will need to be clarified. In addition, further validation studies of the shortened, four-item CAM instrument are needed. The negative predictive accuracy of the CAM may be poorer in populations with a lower prevalence of delirium.
In a preliminary study (53) , subjects with a diagnosis of delirium according to the CAM had significantly higher rates of death, medical complications, and prolonged hospital stay than did those without delirium, even after controlling for underlying illness severity. The CAM's ability to predict clinical outcomes associated with delirium supports the CAM's predictive validity (48) .
A major reason for the underdiagnosis of and the high complication rate associated with delirium has been the absence of a clinically useful measure. The use of the newly validated and standardized CAM may lead to improved recognition, increased diagnostic accuracy, and earlier intervention for delirium. Ultimately, its use may reduce the morbidity and mortality of this devastating condition, particularly in hospitalized high-risk elderly patients treated on general medical and surgical services. Because the CAM is highly sensitive, rapid, and simple, it may be useful for widespread, daily assessment of delirium in persons in high-risk settings. Because of the high rates of morbidity and mortality and the prolonged length of hospital stay associated with delirium, such assessment may be important for quality assurance. In addition, the CAM provides a useful tool for training physicians and nurses to recognize delirium. It also serves as a means of systematizing and recording clinical observations. Finally, the CAM provides a much needed standardized diagnostic tool for use in clinical research on delirium, an area in which further studies remain vitally important.
This study was completed while Dr. Inouye was a Robert Wood Johnson Clinical Scholar at Yale University and while Dr. Alessi was a fellow in Geriatric Medicine at the University of Chicago.
